1K. Junker,T. Wiethege,K.-M. Müller,M. Thomas.p53 tumour-suppressor gene in non-small-cell lung cancer with neoadjuvant therapy[J].Journal of Cancer Research and Clinical Oncology.2000(4)
2H.-U. Kauczor,M. Schuler,C. P. Heussel,A. von Weymarn,G. Bongartz,C. Rochlitz,C. Huber,M. Thelen.CT-guided intratumoral gene therapy in non-small-cell lung cancer[J].European Radiology.1999(2)
3Bauer,J.H,Helfand,S.L.New tricks of an old mole-cule: lifespan regulation by p53[].Aging Cell.2006
4Frasci,G,Panza,N,Comella,G,Pcillio,G.Is there any impact of new drugs on the outcome of advanced NSCLC- An overview of the Southern Italy Cooperative Oncology Group trials[].The Oncologist.1999
5Guan,Y.S,Liu,Y,Zhou,X.P,Li,X,He,Q,Sun,L.p53 gene (Gendicine) and embolization overcame recur-rent hepatocellular carcinoma[].Gut.2005
6Junker,K,Wiethege,T,Muller,K.M,Thomas,M.p53 tumour-suppressor gene in non-small-cell lung can-cer with neoadjuvant therapy[].J Cancer Res Clin Oncol.2000
7Lowe,S.W.Cancer gene therapy and p53[].Current Opinion in Oncology.1995
8Peng,Z.Current status of gendicine in China: recom-binant human Ad-p53 agent for treatment of cancers[].Human Gene Therapy.2005
10Schuler,M,Herrmann,R,de Greve,J.L,Stewart,A.K,Gatzemeier,U,Stewart,D.J,Laufman,L,Gralla,R,Kuball,J,Buhl,R.et al.Adenovirus-mediated wild-type p53 gene transfer in patients receiving chemo-therapy for advanced non-small-cell lung cancer: results of a multicenter phase II study[].Japanese Journal of Clinical Oncology.2001
